P1293: COMBINING THE IAP ANTAGONIST, TOLINAPANT, WITH A DNA HYPOMETHYLATING AGENT ENHANCES ANTI-TUMOUR MECHANISMS IN PRECLINICAL MODELS OF T-CELL LYMPHOMA.

• M. Sims,
• G. Ward,
• Z. Zhang,
• S. Jueliger,
• M. Davis,
• A. Boxall,
• J. Taylor,
• A. Biondo,
• J. Lyons,
• T. Smyth

Affiliations

M. Sims

1 Translational Sciences

G. Ward

1 Translational Sciences

Z. Zhang

1 Translational Sciences

S. Jueliger

1 Translational Sciences

M. Davis

2 Bioinformatics, Astex Pharmaceuticals Limited, Cambridge, United Kingdom

A. Boxall

2 Bioinformatics, Astex Pharmaceuticals Limited, Cambridge, United Kingdom

J. Taylor

3 Clinical Development, Astex Pharmaceuticals Inc, Pleasanton, United States of America

A. Biondo

1 Translational Sciences

J. Lyons

1 Translational Sciences

T. Smyth

4 DMPK, Astex Pharmaceuticals Limited, Cambridge, United Kingdom